Topic

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Articles

As we reach further afield in the molecular universe, we encounter new types of problems to resolve.

Process Development Struggles with Molecular Diversity

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Dame Deborah James’ legacy and the millions raised through her campaigning will undoubtedly be a big boost to clinical research, ultimately providing new and promising treatments for bowel cancer patients. 

Bottoms Up! Research into Bowel Cancer Therapies Gain Funding Boost

Cases of monkeypox are rising around the world, but it is unlikely the virus will become a pandemic problem.

An Unusual Threat: Pharma is Already Tackling the Monkeypox Outbreak

The Next Pandemic

A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.

Law and Pharma

Fresh insight is instrumental in the discussion of novel analytics.

Dual Modality and New Analyses

The AMR Action Fund has made its first investments, marking an important step forward for the partnership to achieve its goal of bringing new treatments to the market for priority pathogens.

A Future Investment

3D cell cultures could provide key avenues to unlocking critical information.

Next Level Interrogation

As Russia’s invasion of Ukraine continues, industry leaders speak out in condemnation of the actions taking place and pledge to provide aid to those in need.

Standing in Solidarity

Borrowing is good, but invention is best.

From the Editor